HUTCHMED (China) (HMDCF) Operating Expenses (2018 - 2021)
HUTCHMED (China)'s (HMDCF) quarterly Operating Expenses came in at -$156.3 million in Q2 2021, down 54.99% year-over-year from -$347.4 million in Q2 2020, and down 8.0% quarter-over-quarter from -$144.8 million in Q1 2021.
Analysis
HUTCHMED (China) (HMDCF) Operating Expenses (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Operating Expenses for 4 consecutive years, with -$156.3 million the latest figure, recorded in Q2 2021.
- On a quarterly basis, Operating Expenses fell 54.99% year-over-year to -$156.3 million in Q2 2021; TTM through Jun 2021 was -$486.0 million, a 34.26% decrease from a year earlier, with the FY2025 full-year figure at -$587.7 million, up 12.8% from the prior year.
- Operating Expenses was -$156.3 million for Q2 2021 at HUTCHMED (China), down from -$144.8 million in the prior quarter.
- Over five years, Operating Expenses peaked at $233.2 million in Q2 2018 and troughed at -$262.4 million in Q2 2019.
- A 4-year average of -$44.2 million and a median of -$84.7 million in 2019 frame the typical range for Operating Expenses.
- The widest YoY moves for Operating Expenses: up 214.04% in 2019, down 218.76% in 2019.
- Over 4 years, Operating Expenses stood at $77.3 million in 2018, then plunged by 218.76% to -$91.8 million in 2019, then fell by 9.9% to -$100.9 million in 2020, then sank by 54.99% to -$156.3 million in 2021.
- The last three Operating Expenses figures came in at -$156.3 million (Q2 2021), -$144.8 million (Q1 2021), and -$100.9 million (Q2 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.20 Bn | 198.21 Bn | 7.24 Bn | 6.54 Bn |
| 2 | Gilead Sciences | 181.83 Bn | 178.65 Bn | 6.22 Bn | 18.20 Bn |
| 3 | Vertex Pharmaceuticals | 132.47 Bn | 124.61 Bn | 2.84 Bn | 2.09 Bn |
| 4 | Regeneron Pharmaceuticals | 82.56 Bn | 74.56 Bn | 3.93 Bn | 3.00 Bn |
| 5 | Argenx Se | 61.59 Bn | 56.40 Bn | 1.37 Bn | -1.05 Bn |
| 6 | Moderna | 54.65 Bn | 49.51 Bn | 52.00 Mn | 960.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.13 Bn | 30.82 Bn | 992.69 Mn | 1.06 Bn |
| 8 | Biogen | 31.42 Bn | 30.13 Bn | 1.96 Bn | 2.60 Bn |
| 9 | Roivant Sciences | 30.21 Bn | 30.21 Bn | 1.16 Mn | 367.83 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | -156.34 Mn |
| Mar 31, 2021 | -144.76 Mn |
| Jun 30, 2020 | -100.87 Mn |
| Mar 31, 2020 | -84.06 Mn |
| Dec 31, 2019 | -91.78 Mn |
| Sep 30, 2019 | -85.29 Mn |
| Jun 30, 2019 | -262.43 Mn |
| Mar 31, 2019 | 88.22 Mn |
| Dec 31, 2018 | 77.28 Mn |
| Sep 30, 2018 | 73.60 Mn |
| Jun 30, 2018 | 233.23 Mn |
| Mar 31, 2018 | -77.36 Mn |